Categories Earnings, Health Care

Earnings Summary: Highlights of Organon’s Q2 2023 results

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023.

  • Second-quarter revenue came in at $1.61 billion, which is up 1% year-over-year
  • Earnings per share increased to $0.95 in the June quarter from $0.92 last year
  • Adjusted earnings were $1.31 per share in Q2, compared to $1.25 per share in the second quarter of 2022
  • The company reported second-quarter adjusted EBITDA of $530 million, which is up 4% annually
  • The management expects full-year 2023 revenue to be in the range of $6.25 billion to $6.45 billion
  • Adjusted EBITDA margin for 2023 is currently expected to be between 31.5% and 33.0%

Most Popular

What to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain

eBay (EBAY): A few factors that helped drive growth in Q3 2024

Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top